FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/05/008583 [Registered on: 17/05/2017] Trial Registered Retrospectively
Last Modified On: 18/05/2017
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Siddha 
Study Design  Single Arm Study 
Public Title of Study   Clinical evaluation of siddha drug Seenthil choornam (internal) and Puzhuvettuthylam (external) in the treatment of Alopecia areata in children. 
Scientific Title of Study
Modification(s)  
Clinical evaluation of siddha drug Seenthil choornam(internal) and Puzhuvettu thylam(external) in the treatment of Puzhuvettu (alopecia areata) in children on open clinical study 
Trial Acronym  Alopecia 
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr M Bakkiyadevi 
Designation  PG Scholar 
Affiliation  National Institute of Siddha 
Address  Department of Kuzhanthai maruthuvam, National institute of siddha, Tambaram Samnatorium.
Department of Kuzhanthai maruthuvam, National institute of siddha, Tambaram Samnatorium.
Kancheepuram
TAMIL NADU
600047
India 
Phone  9994627411  
Fax    
Email  bakkiyadevim@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr M Meenakshi sundaram 
Designation  Associate professor Head of the Dept i/c 
Affiliation  National Institute of Siddha 
Address  Department of Kuzhanthai maruthuvam, National institute of siddha, Tambaram Samnatorium.
Department of Kuzhanthai maruthuvam, National institute of siddha, Tambaram Samnatorium.
Kancheepuram
TAMIL NADU
600047
India 
Phone  9444214582  
Fax  04422381314  
Email  mmssiddha@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr M Meenakshi sundaram 
Designation  Associate professor Head of the Dept i/c 
Affiliation  National Institute of Siddha 
Address  Department of Kuzhanthai maruthuvam, National institute of siddha, Tambaram Samnatorium.
Department of Kuzhanthai maruthuvam, National institute of siddha, Tambaram Samnatorium.

TAMIL NADU
600047
India 
Phone  9444214582  
Fax  04422381314  
Email  mmssiddha@rediffmail.com  
 
Source of Monetary or Material Support  
Ayothidoss pandithar hospital National institute of siddha Tambaram sanatorium chennai-47 
 
Primary Sponsor  
Name  Ayothidoss pandithar hospital  
Address  Natoinal institute of siddha Tambaram sanatorium. 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr M Bakkiyadevi  Ayothidoss Pandithar Hospital, National Institute of Siddha  OPD NO 9 and IPD,Department of Kuzhandhai maruthuvam, National institute of siddha, tambaram sanatorium
Kancheepuram
TAMIL NADU 
9994627411

bakkiyadevim@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Alopecia areata,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  nil  nil 
Intervention  Seenthil choornam(internal) and Puzhuvettu thylam (external)  350-700 mg bd with sugar for 45 days and Puzhuvettu thylam for external apply 
 
Inclusion Criteria  
Age From  6.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  1)Scattered long hair within the bald area
2)Unscarring
3)The area of hair loss may tingle or be painful
4)Affecting region is small
5)Hair loss present on the patches
6)Patients who are satisfying minimum of 3-4 above mentioned symptoms
7)Patient willing to undergo routine blood investigation. 
 
ExclusionCriteria 
Details  1) Loss of hair in the shape of a way at the circumference of the head
2) Scarring alopecia
3)In case of severe hair loss
4) Alopecia tottalis
5) Vitiligo
6)Atopic dermatitis
7) Thyroid disease
8)Down syndrome 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Primary outcome is mainly assessed by severity of Alopecia tool score(SALT SCORE)  45 days 
 
Secondary Outcome  
Outcome  TimePoints 
Secondary outcome is assessed by comparing the following parameters before and after the treatment
1) Improvement in clinical symptoms
2) Any changes in before and after photographs.
 
45 days 
 
Target Sample Size   Total Sample Size="10"
Sample Size from India="10" 
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   02/01/2017 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   It is the single non-randomized,open label trial to determine the efficacy of Seenthil choornam (internal) and Puzhuvettu thylam (external) prepared from herbal constitutents in the patients with Puzhuvettu (Alopecia areata). In this trial 10 patients will be recruited and the trial drug will be administered 350mg - 700mg Twice a day with sugar for a period of 45 days. During the trial period if any AE/SAE/SUSAR will be noticed and refered to pharmacovigilance department in NIS and further management will also be given in NIS OPD/IPD. The entire trial will be monitored by the research monitoring committee of NIS.  During this trial all the safety efficacy parameters will be recorded in the CRF.  After completion of the trial all the study related data will be analysed statistically. The outcome of this trial will be published in India Journal of Medical research. 
Close